“Canadians have only access to eighteen per cent of all innovative medicines that are available around the world. Americans have access to over 90 per cent,” explains Dr. Bettina Hamelin, President and CEO of Innovative Medicines Canada, which represents Canadian pharmaceutical companies.
“Organisation for Economic Co-operation and Development (OECD) countries, which are the richer countries in this world, have access to about 28 per cent [of innovative medicines]”, Hamelin says from her Toronto office, explaining that the big problems are time and money.
